uniQure (QURE) Stock: Buy, Sell, or Hold?
QURE - uniQure N.V.
$44.51
0.04 (0.09%)
â˛
5d:
-0.78%
30d:
-1.37%
90d:
+65.96%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $44.50 · last confirmed Sep 9, 2026
Strength: 7.4/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: QURE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: QURE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $44.51, which is considered fair relative to its 30-day fair value range of $44.96 to $49.01.
Technical Outlook: Technically, QURE is in a strong uptrend. Immediate support is located at $43.05, while resistance sits at $50.97.
Market Sentiment: QURE scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.66 (+56.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QURE is in a strong uptrend. Immediate support is located at $43.05, while resistance sits at $50.97.
Market Sentiment: QURE scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.66 (+56.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$44.96 -
$49.01
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding QURE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 56.5% below Wall St target ($69.66)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$44.96 -
$49.01
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$43.05
Resistance Level
$50.97
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.92
Wall Street Target
$69.66
(+56.5%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: September 13, 2026 3:44 PM ET
Data refreshes hourly during market hours. Next update: 4:44 PM
Data refreshes hourly during market hours. Next update: 4:44 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 48 HOLD |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
